Amenorrhea (Nursing)


Learning Outcome

  1. Describe the causes of amenorrhea.
  2. Recall the presentation of amenorrhea.
  3. Summarize the evaluation of amenorrhea.

Introduction

Typically, the female menstrual cycle comprises a 28 to 30-day cycle containing 2 phases: the proliferative and secretory phases. The uterine lining sheds at the end of the cycle, known as menstruation.[1][2][3] Throughout each stage of a woman's reproductive life cycle, from menarche to menopause, there may be variations in their menstrual cycle's length and amount secondary to many causes. This variation may be within the normal range or pathologic. Particularly during stages of the reproductive cycle (eg, menarche and perimenopause), when longer intervals between menstrual cycles commonly occur, clinicians may be unsure of the appropriate diagnostic studies or whether an evaluation is even indicated.

Amenorrhea is abnormal uterine bleeding characterized by the absence of menstruation in a female of reproductive age, 12 to 52 years on average.[4] It can be classified as either primary or secondary amenorrhea. Primary amenorrhea is defined as having no history of menstruation by the age of 15 years or 3 years after thelarche; secondary amenorrhea is defined as the absence of menses for ≥3 months in a woman with previously regular menstrual cycles or ≥6 months in any woman with at least one previous spontaneous menstruation.[4][5] Patients meeting the criteria for either primary or secondary amenorrhea warrant an evaluation. However, an evaluation for delayed puberty is indicated in adolescents aged 13 years with primary amenorrhea and no breast development.[6][7]

There are numerous potential etiologies of amenorrhea. Most underlying causes can be classified into general groups: outflow tract abnormalities; primary ovarian insufficiency; hypothalamic or pituitary disorders; other endocrine gland disorders; and physiologic or medication induced.[8][9] When evaluating a patient with amenorrhea, a systematic approach should be used to consider each potential etiology. The initial work-up usually includes a comprehensive history and physical examination, a urine pregnancy test, serum hormone testing, and pelvic imaging. Additional testing may also be indicated based on the clinical presentation.[6][8][9] Treatment depends on the underlying etiology and may include lifestyle interventions, hormone therapy or other medications, surgery, and mental health services.

Nursing Diagnosis

  • Cessation of menstruation
  • Anxiety
  • Low self-esteem
  • Sexual dysfunction

Causes

Amenorrhea is the absence of menstruation in a female of reproductive age. It can be classified as either primary or secondary amenorrhea. Primary amenorrhea is defined as having no history of menstruation by the age of 15 years or 3 years after thelarche; secondary amenorrhea is defined as the absence of menses for ≥3 months in a woman with previously regular menstrual cycles or ≥6 months in any woman with at least one previous spontaneous menstruation. Patients meeting the criteria for either primary or secondary amenorrhea warrant an evaluation. Additionally, an assessment for delayed puberty is indicated in adolescents aged 13 years and younger without initial breast development.

Congenital or anatomic abnormalities are most commonly the cause of primary amenorrhea. However, any etiology of secondary amenorrhea may also present as primary amenorrhea. Determining the underlying cause of amenorrhea will assist in guiding management decisions.[9] Menstruation is controlled by hormones secreted from the hypothalamus, pituitary gland, and ovary. Dysfunction in any of these three organs can result in amenorrhea; therefore, numerous potential etiologies exist. Most underlying causes can be classified into general groups: outflow tract abnormalities; primary ovarian insufficiency; hypothalamic or pituitary disorders; other endocrine gland disorders; and physiologic or medication induced.[8][9] When evaluating a patient with amenorrhea, a systematic approach should be used to consider each potential etiology. 

Risk Factors

Amenorrhea is not life-threatening, but the loss of the menstrual cycle can indicate severe underlying pathology. The ovarian hormone estrogen helps promote bone mineral density; therefore, if the underlying abnormality results in low estrogen, the patient has a higher risk of osteoporosis and fractures.

Assessment

During the history and physical examination, clinicians first need to ask about the patient's age and at what age the patient started menses during puberty (ie, menarche). This information is important to determine and differentiate between primary and secondary amenorrhea. If the patient was not menstruating, it must be primary amenorrhea. All other cases will be secondary amenorrhea.[10][11] 

It is essential to ask about symptoms that may suggest a potential cause for the patient's amenorrhea. One of the most crucial causes to rule out is pregnancy. Pregnancy symptoms include nausea, vomiting, fatigue, constipation, and breast tenderness. 

Clinical evidence that may suggest a hypothalamic disorder includes a low body mass index, a restrictive diet or eating disorder, and intense athletic training. A rare hypothalamic cause of amenorrhea is called Kallman syndrome, which results from an absence of specific neurons in the brain, resulting in amenorrhea and anosmia (ie, an inability to smell).

One of the most common pituitary causes of amenorrhea is a prolactin-secreting pituitary gland tumor called prolactinoma. Prolactin is the hormone responsible for producing breast milk. It is elevated naturally during lactation. Abnormal elevations in prolactin from a prolactinoma can result in milky nipple discharge in nonbreastfeeding patients, known as galactorrhea. Additionally, pituitary tumors can compress the optic chiasm and lead to visual disturbances or headaches.

Ovarian abnormalities include primary ovarian insufficiency (POI) and gonadal dysgenesis (ie, abnormal formation of the gonads). If the ovaries are unable to produce estrogen and progesterone, the endometrium will not be stimulated; menses will not occur. Signs of low estrogen include vaginal dryness, painful intercourse, hot flashes, and mood swings. Menopause naturally occurs in the early 50s but may occur in the 40s as well. POI refers to ovarian dysfunction resulting in cessation of menses before age 40. Patients with a history of autoimmune disease, chemotherapy, or radiation are at increased risk for POI.

Other endocrine disorders may also affect the HPO axis. The most common condition is polycystic ovary syndrome (PCOS). These patients have abnormally high levels of androgens (eg, testosterone), which can lead to male-pattern hair growth (eg, facial hair, chest hair) and acne.

A history of medication use is significant because antipsychotics are one of the most common causes of high prolactin levels, which lead to amenorrhea. The use of hormonal contraception, cocaine, opioids, and antiepileptics can also cause the failure of menstruation. Infiltrative diseases (eg, neurosarcoidosis, hemochromatosis, or cancer) and any chronic illness could also be causing amenorrhea.

Physical examination includes the general physical examination, which can be used to look for etiologic clues. The examination also should consist of the following:

  • Measuring height, weight, and vital signs
  • Calculation of body mass index (BMI) 
  • Skin assessment for hirsutism, hair loss, or acne to investigate possible hyperandrogenemia
  • Heart and lung exam for evidence of chronic disease
  • Abdominal exam for signs of chronic illness or pelvic masses
  • A breast exam for signs of nipple discharge; in adolescents, the maturation of the breasts should be noted (eg, Tanner staging)
  • A pelvic exam for anatomic abnormalities; the outflow tract should be assessed for patency, and maturation of the external genitals and pubic hair should be noted.

Evaluation

Diagnostic studies should include the following:

  • Beta hCG to exclude pregnancy 
  • Prolactin level to exclude prolactinoma
  • Testosterone and dehydroepiandrosterone sulfate (DHEAS) for exclusion of hyperandrogenism
  • Follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estradiol to evaluate HPO axis function
  • Pelvic ultrasound to assess the internal pelvic organs, including the uterus and ovaries
  • Karyotyping if clinical suspicion for Turner syndrome, gonadal dysgenesis, müllerian agenesis (ie, absent uterus), or a disorder of sexual development (eg, complete androgen insensitivity syndrome)

Medical Management

Treatment mainly depends on the cause of amenorrhea. If the cause of amenorrhea is premature ovarian insufficiency (POI) or permanent HPO axis dysfunction, hormone replacement therapy (HRT) is indicated. Anatomic obstructions of the menstrual outflow tract require surgical correction. If amenorrhea is due to malnutrition, a proper diet plan can cure the patient successfully. For anorexia nervosa and stress-induced amenorrhea, cognitive-behavioral therapy and antidepressants can help. Dopamine agonist drugs like cabergoline can treat prolactinoma; if large, surgery can be curative. PCOS is typically treated with lifestyle modifications and combined oral contraceptive pills (OCPs), which help regulate menstruation and reduce hyperandrogenemia.[12][13][14]

Nursing Management

  • Provide support.
  • Encourage increased nutritional intake if the patient has a low body weight.
  • Educate patients on the causes of amenorrhea.
  • Educate patients that amenorrhea not intentionally induced by contraceptive medications (eg, continuous OCPs) may indicate a severe underlying condition.

When To Seek Help

Consultation with the appropriate specialized clinician should be sought for any of the following:

  • Menarche has not occurred by age 15
  • Menarche has not occurred within 3 years of initial breast development
  • No signs of puberty by age 13
  • No menstrual for 3 cycle lengths if previous cycles were regular or if no cycle in over 6 months if previous cycles were previously irregular
  • Galactorrhea
  • Vision changes, neurologic deficits, or headache symptoms
  • Evidence of bone fracture
  • Signs of mental health disorder (eg, depression)

Outcome Identification

  • Achieve regular menstrual cycles.
  • Resume fertility.

Monitoring

  • Menstrual patterns
  • Weight and BMI
  • Bone mineral density (BMD) monitoring in patients with longstanding hypothalamic dysfunction
  • Vital signs and cholesterol levels in patients with PCOS or at high risk for metabolic diseases (eg, hypertension and diabetes mellitus)
  • Mood

Coordination of Care

Amenorrhea is a common problem at some point in the life of most females. After ruling out pregnancy, however, determining the cause can be a challenge. Aside from the gynecologist, the disorder is best managed by a multidisciplinary team of healthcare workers, including an endocrinologist, dietitian, internist, mental health worker, and fertility expert. The outcomes in women with amenorrhea depend on the cause. Some women with PCOS need lifelong treatment as they are at high risk for adverse cardiac events and metabolic syndrome. Patient education is vital, and the patient should be encouraged to pay attention to factors that affect bone density. In addition, these women need to eat a healthy diet fortified with calcium and participate in regular exercise.[2][15] 

Health Teaching and Health Promotion

  • Eat a healthy diet.
  • Instruct athletic patients that increased caloric intake requires intense, vigorous training.
  • Instruct patients with a higher risk of osteoporosis to take vitamin D and calcium supplements.

Pearls and Other issues

The causes of amenorrhea are diverse, and an interprofessional approach is required. Premenopausal patients must be followed up for several years to ensure the menstrual cycle has returned.


Details

Author

Gul Nawaz

Author

Alan D. Rogol

Updated:

2/25/2024 12:45:03 PM

References

[1]

Munro MG, Balen AH, Cho S, Critchley HOD, Díaz I, Ferriani R, Henry L, Mocanu E, van der Spuy ZM, FIGO Committee on Menstrual Disorders and Related Health Impacts, and FIGO Committee on Reproductive Medicine, Endocrinology, and Infertility The FIGO ovulatory disorders classification system. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2022 Oct     [PubMed PMID: 35983674]

[2]

Munro MG, Balen AH, Cho S, Critchley HOD, Díaz I, Ferriani R, Henry L, Mocanu E, van der Spuy ZM, FIGO Committee on Menstrual Disorders and Related Health Impacts, and FIGO Committee on Reproductive Medicine, Endocrinology, and Infertility. The FIGO Ovulatory Disorders Classification System†. Human reproduction (Oxford, England). 2022 Sep 30:37(10):2446-2464. doi: 10.1093/humrep/deac180. Epub     [PubMed PMID: 35984284]

[3]

Sharp HT, Johnson JV, Lemieux LA, Currigan SM. Executive Summary of the reVITALize Initiative: Standardizing Gynecologic Data Definitions. Obstetrics and gynecology. 2017 Apr:129(4):603-607. doi: 10.1097/AOG.0000000000001939. Epub     [PubMed PMID: 28277367]

[4]

. ACOG Committee Opinion No. 651: Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign. Obstetrics and gynecology. 2015 Dec:126(6):e143-e146. doi: 10.1097/AOG.0000000000001215. Epub     [PubMed PMID: 26595586]

[5]

Rundell K, Panchal B. Being Reproductive. Primary care. 2018 Dec:45(4):587-598. doi: 10.1016/j.pop.2018.07.003. Epub 2018 Oct 5     [PubMed PMID: 30401343]

[6]

Practice Committee of American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertility and sterility. 2008 Nov:90(5 Suppl):S219-25. doi: 10.1016/j.fertnstert.2008.08.038. Epub     [PubMed PMID: 19007635]

[7]

Klein DA, Paradise SL, Reeder RM. Amenorrhea: A Systematic Approach to Diagnosis and Management. American family physician. 2019 Jul 1:100(1):39-48     [PubMed PMID: 31259490]

[8]

. Committee opinion: no. 562: müllerian agenesis: diagnosis, management, and treatment. Obstetrics and gynecology. 2013 May:121(5):1134-1137. doi: 10.1097/01.AOG.0000429659.93470.ed. Epub     [PubMed PMID: 23635766]

[9]

Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannopoulou K, MacDougall J. Androgen insensitivity syndrome. Lancet (London, England). 2012 Oct 20:380(9851):1419-28. doi: 10.1016/S0140-6736(12)60071-3. Epub 2012 Jun 13     [PubMed PMID: 22698698]

[10]

Singh N, Sethi A. Endometritis - Diagnosis,Treatment and its impact on fertility - A Scoping Review. JBRA assisted reproduction. 2022 Aug 4:26(3):538-546. doi: 10.5935/1518-0557.20220015. Epub 2022 Aug 4     [PubMed PMID: 35621273]

[11]

Berman JM. Intrauterine adhesions. Seminars in reproductive medicine. 2008 Jul:26(4):349-55. doi: 10.1055/s-0028-1082393. Epub     [PubMed PMID: 18756412]

[12]

Sophie Gibson ME, Fleming N, Zuijdwijk C, Dumont T. Where Have the Periods Gone? The Evaluation and Management of Functional Hypothalamic Amenorrhea. Journal of clinical research in pediatric endocrinology. 2020 Feb 6:12(Suppl 1):18-27. doi: 10.4274/jcrpe.galenos.2019.2019.S0178. Epub     [PubMed PMID: 32041389]

[13]

Klein DA, Emerick JE, Sylvester JE, Vogt KS. Disorders of Puberty: An Approach to Diagnosis and Management. American family physician. 2017 Nov 1:96(9):590-599     [PubMed PMID: 29094880]

[14]

Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA, Endocrine Society. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. The Journal of clinical endocrinology and metabolism. 2011 Feb:96(2):273-88. doi: 10.1210/jc.2010-1692. Epub     [PubMed PMID: 21296991]

[15]

Haider SA, Levy S, Rock JP, Craig JR. Prolactinoma: Medical and Surgical Considerations. Otolaryngologic clinics of North America. 2022 Apr:55(2):305-314. doi: 10.1016/j.otc.2021.12.005. Epub 2022 Mar 4     [PubMed PMID: 35256169]

[16]

. Committee opinion no. 605: primary ovarian insufficiency in adolescents and young women. Obstetrics and gynecology. 2014 Jul:124(1):193-197. doi: 10.1097/01.AOG.0000451757.51964.98. Epub     [PubMed PMID: 24945456]

[17]

King TF, Conway GS. Swyer syndrome. Current opinion in endocrinology, diabetes, and obesity. 2014 Dec:21(6):504-10. doi: 10.1097/MED.0000000000000113. Epub     [PubMed PMID: 25314337]

[18]

American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstetrics and gynecology. 2018 Jun:131(6):e157-e171. doi: 10.1097/AOG.0000000000002656. Epub     [PubMed PMID: 29794677]

[19]

Milano W, Colletti C, Capasso A. Hyperprolactinemia Induced by Antipsychotics: From Diagnosis to Treatment Approach. Endocrine, metabolic & immune disorders drug targets. 2017:17(1):38-55. doi: 10.2174/1871530317666170424102332. Epub     [PubMed PMID: 28440197]

[20]

Calik-Ksepka A, Stradczuk M, Czarnecka K, Grymowicz M, Smolarczyk R. Lactational Amenorrhea: Neuroendocrine Pathways Controlling Fertility and Bone Turnover. International journal of molecular sciences. 2022 Jan 31:23(3):. doi: 10.3390/ijms23031633. Epub 2022 Jan 31     [PubMed PMID: 35163554]

[21]

. ACOG Practice Bulletin No. 141: management of menopausal symptoms. Obstetrics and gynecology. 2014 Jan:123(1):202-216. doi: 10.1097/01.AOG.0000441353.20693.78. Epub     [PubMed PMID: 24463691]

[22]

Reindollar RH, Byrd JR, McDonough PG. Delayed sexual development: a study of 252 patients. American journal of obstetrics and gynecology. 1981 Jun 15:140(4):371-80     [PubMed PMID: 7246652]

[23]

Pettersson F, Fries H, Nillius SJ. Epidemiology of secondary amenorrhea. I. Incidence and prevalence rates. American journal of obstetrics and gynecology. 1973 Sep 1:117(1):80-6     [PubMed PMID: 4722382]

[24]

Munro MG, Critchley HOD, Fraser IS, FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2018 Dec:143(3):393-408. doi: 10.1002/ijgo.12666. Epub 2018 Oct 10     [PubMed PMID: 30198563]

[25]

Lang-Muritano M, Sproll P, Wyss S, Kolly A, Hürlimann R, Konrad D, Biason-Lauber A. Early-Onset Complete Ovarian Failure and Lack of Puberty in a Woman With Mutated Estrogen Receptor β (ESR2). The Journal of clinical endocrinology and metabolism. 2018 Oct 1:103(10):3748-3756. doi: 10.1210/jc.2018-00769. Epub     [PubMed PMID: 30113650]

[26]

Master-Hunter T, Heiman DL. Amenorrhea: evaluation and treatment. American family physician. 2006 Apr 15:73(8):1374-82     [PubMed PMID: 16669559]

[27]

Gordon CM, Ackerman KE, Berga SL, Kaplan JR, Mastorakos G, Misra M, Murad MH, Santoro NF, Warren MP. Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2017 May 1:102(5):1413-1439. doi: 10.1210/jc.2017-00131. Epub     [PubMed PMID: 28368518]

[28]

. Screening and Management of the Hyperandrogenic Adolescent: ACOG Committee Opinion, Number 789. Obstetrics and gynecology. 2019 Oct:134(4):e106-e114. doi: 10.1097/AOG.0000000000003475. Epub     [PubMed PMID: 31568365]

[29]

Martin KA, Anderson RR, Chang RJ, Ehrmann DA, Lobo RA, Murad MH, Pugeat MM, Rosenfield RL. Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2018 Apr 1:103(4):1233-1257. doi: 10.1210/jc.2018-00241. Epub     [PubMed PMID: 29522147]

[30]

Eggermann T, Ledig S, Begemann M, Elbracht M, Kurth I, Wieacker P. Search for altered imprinting marks in Mayer-Rokitansky-Küster-Hauser patients. Molecular genetics & genomic medicine. 2018 Nov:6(6):1225-1228. doi: 10.1002/mgg3.426. Epub 2018 Aug 11     [PubMed PMID: 30099855]

[31]

ACOG Committee Opinion No. 728: Müllerian Agenesis: Diagnosis, Management, And Treatment.,, Obstetrics and gynecology, 2018 Jan     [PubMed PMID: 29266078]

[32]

Amies Oelschlager AM, Debiec K. Vaginal Dilator Therapy: A Guide for Providers for Assessing Readiness and Supporting Patients Through the Process Successfully. Journal of pediatric and adolescent gynecology. 2019 Aug:32(4):354-358. doi: 10.1016/j.jpag.2019.05.002. Epub 2019 May 12     [PubMed PMID: 31091469]

[33]

Edmonds DK, Rose GL, Lipton MG, Quek J. Mayer-Rokitansky-Küster-Hauser syndrome: a review of 245 consecutive cases managed by a multidisciplinary approach with vaginal dilators. Fertility and sterility. 2012 Mar:97(3):686-90. doi: 10.1016/j.fertnstert.2011.12.038. Epub 2012 Jan 21     [PubMed PMID: 22265001]

[34]

. ACOG Committee Opinion No. 740: Gynecologic Care for Adolescents and Young Women With Eating Disorders. Obstetrics and gynecology. 2018 Jun:131(6):e205-e213. doi: 10.1097/AOG.0000000000002652. Epub     [PubMed PMID: 29794682]

[35]

Shufelt CL, Torbati T, Dutra E. Hypothalamic Amenorrhea and the Long-Term Health Consequences. Seminars in reproductive medicine. 2017 May:35(3):256-262. doi: 10.1055/s-0037-1603581. Epub 2017 Jun 28     [PubMed PMID: 28658709]

[36]

Hoyt LT, Falconi AM. Puberty and perimenopause: reproductive transitions and their implications for women's health. Social science & medicine (1982). 2015 May:132():103-12. doi: 10.1016/j.socscimed.2015.03.031. Epub 2015 Mar 14     [PubMed PMID: 25797100]